Gibson Oncology, LLC
Develops orphan-designated drugs for glioblastoma and other gliomas and conducts/plans Phase I–II clinical trials to advance brain-cancer therapies in collaboration with research institutions.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
